Discover how advanced lymphedema diagnostics—including NIRF imaging, lymphoscintigraphy, and AI-driven analysis—are revolutionizing patient care and transforming the market. A chronic often disabling ...

A five-factor risk model effectively predicted 2-year lymphedema-free survival among a cohort of patients with breast cancer, ...

Q4 2024 Earnings Call Transcript February 18, 2025 Tactile Systems Technology, Inc. beats earnings expectations. Reported EPS ...

Welcome, ladies and gentlemen, to the fourth quarter and fiscal year 2024 earnings conference call for Tactile Medical. (Operator Instructions) Please note that this conference call is being recorded ...

He was born July 24, 1935 in St. Louis, MO the son of the late Delilah Osburn. Melvin was self-employed with his own lawn service. Melvin was a strong Lymphedema Patient Advocate. He helped to get The ...

Healthpoint to offer advanced therapies for lipedema and lymphedema via a dedicated multidisciplinary team, ensuring ...

Tactile Systems projects 2025 full-year revenue between $316 million and $322 million, representing an 8%-10% year-over-year growth. Guidance assumes 8%-10% growth in the Lymphedema product line and 6 ...

Tactile Systems Technology, Inc. ("Tactile Medical"; the "Company") (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic ...